Crossmark

Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1007/s10072-023-07028-9

Published Online: 2023-09-06

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niu, Xiaoqian

Wang, Yuye

Zhang, Xiangfei

Wang, Yu

Shao, Wen

Chen, Leian

Yang, Ziyuan

Peng, Dantao https://orcid.org/0000-0001-8038-3192
Funding

Funding for this research was provided by:

Central health research project (2020ZD10)

National Key R&D Program of China (2022YFC2010103)
License Information

Text and Data Mining valid from 2023-09-06

Version of Record valid from 2023-09-06
More Information

Article History

Received: 16 February 2023

Accepted: 19 August 2023

First Online: 6 September 2023

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of China-Japan Friendship Hospital (Ethics ID: 2021–1-Y01).

: The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

: Informed consent was obtained from all subjects involved in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below